HCPCS Level IIdrugActive
J3055
Inj talquetamab-tgvs 0.25 mg
BETOS: O1E
Effective: 2024-04-01
Description
Injection, talquetamab-tgvs, 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Talvey
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
0.25 MG
Billing Units
12.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.